Literature DB >> 8561698

Clinical assessment of squamous cell carcinoma of the nasal cavity proper.

A Kida1, S Endo, H Iida, Y Yamada, F Sakai, T Furusaka, K Ishiyama.   

Abstract

The subjects were 14 patients with squamous cell carcinoma or undifferentiated carcinoma of the nasal cavity treated at Nihon University Hospital between October 1984 and November 1991, who were followed for at least 3 years. The site of the tumor origin within the nasal cavity was the lateral wall in 8 patients, the nasal septum in three patients, and unknown in three patients. Histologically, there were 13 squamous cell carcinomas in (3 well differentiated, 7 moderately differentiated, and 3 poorly differentiated) and 1 undifferentiated carcinoma. Treatment was by a combination of radiotherapy, chemotherapy, and surgery in 8 cases, a combination of radiotherapy and surgery in 5 cases, and surgery alone in 1 case. The 3-year and 5-year Kaplan-Meier survival rates were 86 and 69%, respectively. A total of 6 patients suffered a recurrence, with local recurrence occurring in 4 patients and pulmonary metastasis in 2 patients. Tumor control was achieved in 3 of the 4 cases of local recurrence by reoperation, and by surgery in 1 of the 2 cases of pulmonary metastasis. The duration of the recurrence-free interval in the patients who developed local recurrences, 18 to 46 months after the completion of the initial course of therapy, was of considerable interest.

Entities:  

Mesh:

Year:  1995        PMID: 8561698     DOI: 10.1016/s0385-8146(12)80055-1

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  2 in total

Review 1.  New Brain Lymphatic Vessels Drain Old Concepts.

Authors:  Lasse Dissing-Olesen; Soyon Hong; Beth Stevens
Journal:  EBioMedicine       Date:  2015-08-14       Impact factor: 8.143

2.  Salivary duct carcinoma arising from the inferior turbinate.

Authors:  Nimisha Vallabh; Venkat Srinivasan; David Hughes; David Agbamu
Journal:  J Surg Case Rep       Date:  2017-07-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.